Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet Neurology2019Vol. 18(3), pp. 269–285
Citations Over TimeTop 1% of 2019 papers
Mitchell T. Wallin, William J. Culpepper, Emma Nichols, Zulfiqar A Bhutta, Tsegaye Tewelde Gebrehiwot, Simon I Hay, Fakher Rahim, Kristopher J Krohn, Xiaofeng Liang, Mohsen Naghavi, Ali H. Mokdad, Molly R Nixon, Robert C. Reiner, Benn Sartorius, Mari Smith, Roman Topór-Mądry, Andrea Werdecker, Theo Vos, Valery L. Feigin, Christopher J L Murray
Abstract
Bill & Melinda Gates Foundation.
Related Papers
- → Patient perspectives about multiple sclerosis: A metaphor study(2024)3 cited
- → Erythrocyte membrane fatty acids in patients with multiple sclerosis(2009)19 cited
- → Relation of fingolimod treatment to disability in multiple sclerosis(2017)
- → Astrocytes in the pathogenesis of multiple sclerosis(2021)
- → Role of Plasma MicroRNAs 145 and 484 in Diagnosis of Multiple Sclerosis, Disease Activity and the Transition from Relapsing Remitting Multiple Sclerosis to Secondary Progressive Multiple Sclerosis(2023)